- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x THG: (6S)-5,6,7,8-TETRAHYDROFOLATE(Non-covalent)
THG.2: 17 residues within 4Å:- Chain A: V.26, V.27, A.28, D.48, M.49, F.52, R.53, I.84, P.85, F.88, L.91, P.92, R.94, I.154, Y.160, T.178
- Ligands: NAP.1
14 PLIP interactions:14 interactions with chain A- Hydrophobic interactions: A:F.52, A:F.52, A:F.88
- Hydrogen bonds: A:V.26, A:D.48, A:Y.160, A:T.178, A:T.178
- Water bridges: A:R.53
- Salt bridges: A:D.48, A:R.53, A:R.53, A:R.94
- pi-Stacking: A:F.52
THG.18: 15 residues within 4Å:- Chain B: V.26, V.27, A.28, D.48, M.49, F.52, R.53, P.85, F.88, P.92, R.94, I.154, Y.160, T.178
- Ligands: NAP.20
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:F.52, B:F.52, B:F.88, B:F.88
- Hydrogen bonds: B:V.26, B:Y.160, B:T.178, B:T.178
- Salt bridges: B:D.48, B:R.53, B:R.94
- pi-Stacking: B:F.52
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
UMP.3: 12 residues within 4Å:- Chain A: C.403, H.404, Q.422, R.423, S.424, D.426, G.430, N.434, H.464, Y.466
- Chain B: R.383, R.384
12 PLIP interactions:4 interactions with chain B, 8 interactions with chain A- Water bridges: B:R.384, B:R.384
- Salt bridges: B:R.383, B:R.384, A:R.423
- Hydrogen bonds: A:Q.422, A:S.424, A:S.424, A:D.426, A:N.434, A:N.434, A:H.464
UMP.19: 16 residues within 4Å:- Chain A: R.383, R.384
- Chain B: Y.343, C.403, H.404, Q.422, R.423, S.424, C.425, D.426, G.430, N.434, H.464, Y.466
- Ligands: EDO.27, EDO.28
10 PLIP interactions:2 interactions with chain A, 8 interactions with chain B- Salt bridges: A:R.383, A:R.384, B:R.423
- Hydrogen bonds: B:H.404, B:Q.422, B:S.424, B:D.426, B:N.434, B:H.464, B:Y.466
- 26 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 8 residues within 4Å:- Chain A: L.18, A.140, S.141, P.142, T.145, V.488, F.489, R.490
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: A.174, Y.176, K.229, I.231, R.482, A.510
Ligand excluded by PLIPEDO.6: 4 residues within 4Å:- Chain A: A.371, I.372, R.384, L.386
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: I.211, S.212, E.213, E.214, Y.226
Ligand excluded by PLIPEDO.8: 2 residues within 4Å:- Chain A: E.250, G.251
Ligand excluded by PLIPEDO.9: 2 residues within 4Å:- Chain A: H.255, S.467
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: P.68, R.71, N.143, Y.144, S.147, I.148
Ligand excluded by PLIPEDO.11: 4 residues within 4Å:- Chain A: I.248, R.249, V.470, N.474
Ligand excluded by PLIPEDO.12: 8 residues within 4Å:- Chain A: P.66, S.67, P.68, R.71, G.93, R.94, L.95, S.124
Ligand excluded by PLIPEDO.13: 6 residues within 4Å:- Chain A: G.157, Y.160, L.164, F.190, F.191, R.192
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain A: R.286, W.289, Y.509
Ligand excluded by PLIPEDO.15: 3 residues within 4Å:- Chain A: P.46, E.47, K.50
Ligand excluded by PLIPEDO.16: 4 residues within 4Å:- Chain A: V.193, W.206, R.208, L.230
Ligand excluded by PLIPEDO.17: 3 residues within 4Å:- Chain A: K.65, P.66, G.93
Ligand excluded by PLIPEDO.21: 7 residues within 4Å:- Chain B: L.18, A.140, P.142, T.145, V.488, F.489, R.490
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain B: A.174, Y.176, K.229, I.231, R.482, A.510
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain B: I.248, R.249, V.470, N.474
Ligand excluded by PLIPEDO.24: 2 residues within 4Å:- Chain B: H.255, S.467
Ligand excluded by PLIPEDO.25: 8 residues within 4Å:- Chain A: F.350, G.351, N.391, S.393
- Chain B: F.350, G.351, N.391, S.393
Ligand excluded by PLIPEDO.26: 6 residues within 4Å:- Chain A: N.252, F.266
- Chain B: R.271, Y.410, S.412, S.417
Ligand excluded by PLIPEDO.27: 4 residues within 4Å:- Chain B: G.430, F.433
- Ligands: UMP.19, EDO.28
Ligand excluded by PLIPEDO.28: 9 residues within 4Å:- Chain B: E.295, F.299, I.316, W.317, Y.343, H.404, N.434
- Ligands: UMP.19, EDO.27
Ligand excluded by PLIPEDO.29: 3 residues within 4Å:- Chain B: R.249, E.250, G.251
Ligand excluded by PLIPEDO.30: 7 residues within 4Å:- Chain B: G.157, Y.160, A.161, L.164, F.190, F.191, R.192
Ligand excluded by PLIPEDO.31: 2 residues within 4Å:- Chain B: S.212, E.213
Ligand excluded by PLIPEDO.32: 5 residues within 4Å:- Chain A: W.390
- Chain B: A.371, I.372, R.384, L.386
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Di Pisa, F. et al., Crystal structure of Trypanosoma cruzi Dihydrofolate Reductase-Thymidylate Synthase in complex with (6S)-5,6,7,8-TETRAHYDROFOLATE. To Be Published
- Release Date
- 2017-09-20
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.80 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x THG: (6S)-5,6,7,8-TETRAHYDROFOLATE(Non-covalent)
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 26 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Di Pisa, F. et al., Crystal structure of Trypanosoma cruzi Dihydrofolate Reductase-Thymidylate Synthase in complex with (6S)-5,6,7,8-TETRAHYDROFOLATE. To Be Published
- Release Date
- 2017-09-20
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B